AzTrials
AzTrials

Maxillofacial InjuriesNCT04279925

A Clinical Trial of Locally Made Titanium Miniplate and Screw in Maxillofacial Fractures Management

A study testing ORIF (Open reduction internal fixation): locally-made miniplate and screw and ORIF: Imported miniplate and screw in people with Maxillofacial Injuries and Maxillofacial Prosthesis Implantation, run by Universitas Indonesia at 1 site in Indonesia.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The study is a blind randomized clinical study on patients with midface maxillofacial fractures coming to Cipto Mangunkusumo Hospital. The subject is the fracture line who met the inclusion criteria and randomly allocated into the study (locally-made miniplate and screw) and control (BIOMET® miniplate and screw) group… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
ORIF (Open reduction internal fixation): locally-made miniplate and screw and ORIF: Imported miniplate and screw
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
1 siteIndonesia
Study dates
11 Mar 2020to 31 May 2020
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Midface fracture with the indication of surgery
  • Midface fracture sustained within 2 weeks

Who cannot join

  • Comminuted and defect fracture
  • Midface fracture on patients with systemic diseases affecting bone healing.
  • Midface fracture in children
  • Midface fracture in multiple trauma patients with neurological deterioration

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Cipto mangunkusumo National Hospital

    Jakarta Pusat, Central, 10430

Other trials in Indonesia

About this study

The study is a blind randomized clinical study on patients with midface maxillofacial fractures coming to Cipto Mangunkusumo Hospital. The subject is the fracture line who met the inclusion criteria and randomly allocated into the study (locally-made miniplate and screw) and control (BIOMET® miniplate and screw) group through a predetermined randomization list. The healing process is follow up using non-contrast head computed tomography immediately after surgery as a baseline, and 3 months post-op. Afterward, a radiologist consultant as a blinded evaluator will evaluate the score of bone density, and screw loosening, while local tissue reaction after fixation evaluates during the patient's visit outpatient clinic. All scores from points of the evaluation group will be collected and going to statistically evaluated using independent t-test or Mann Whitney test depending on the distribution of the data

Being tested
ORIF (Open reduction internal fixation): locally-made miniplate and screw, ORIF: Imported miniplate and screw
Medical subject headings
Maxillofacial Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ORIF (Open reduction internal fixation): locally-made miniplate and screwDevice

    Fracture lines in this group underwent open reduction internal fixation (ORIF) procedure which consists of realignment of the bone achieved from surgical mean and stabilization of the bone fragments by using locally-made miniplate and screw produced by the Faculty of Engineering Universitas Indonesia. The plate used in the study is a straight plate with 4 and 5 holes with the dimension of 17mm long, 4 mm wide and 0.56 mm thick.

  • ORIF: Imported miniplate and screwDevice

    Fracture lines in this group underwent open reduction internal fixation (ORIF) procedure which consists of realignment of the bone achieved from surgical mean and stabilization of the bone fragments by using Biomet® miniplate 1.5 produced by Biomet, included in the Lorenz® Plating System Midface. The particular plate used in the study is a straight plate with 4 holes, 17mm length and 0.6mm thick, coded 01-7047 in the catalog. Biomet® screw 1.5 utilized in this study is also produced by Biomet, included in the Lorenz® Plating System Midface. The dimension of the screw is 4mm length, 1.5 mm diameter, and coded 91-6104 1.5 mm X-Drive Self drilling screws.

Study groups in NCT04279925
Study groupRoleWhat they receive
Locally-made Miniplate and screwExperimentalLocally-made miniplate and screw produced by the Faculty of Engineering Universitas Indonesia.
Receives: Device: ORIF (Open reduction internal fixation): locally-made miniplate and screw
Imported Miniplate and screwActive comparatorBiomet® miniplate 1.5 and screw 1.5 produced by Biomet, included in the Lorenz® Plating System Midface.
Receives: Device: ORIF: Imported miniplate and screw

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bone Density

    The Hounsfield unit (HU) is a relative quantitative measurement of radio density used by radiologists in the interpretation of computed tomography (CT) images.The Hounsfield unit, also referred to as the CT unit, is then calculated based on a linear transformation of the baseline linear attenuation coefficient of the X-ray beam, where air is usually -1000 HU and air 0 HU. The HU for bones ranges from 148 (cancellous bones) to 3000 (dense bones), -700 to 225 HU for soft tissues, -205 to -72 HU for fat, and -5 to 139 for muscle.

    Measured: 3 months

Secondary outcomes (2)
  1. Screw Loosening (Yes/No)

    Screw loosening will be recorded, whether it is present or not. It will be evaluated by a radiologist consultant after the subject completed all their Head CT evaluation. The outcome will be presented as the percentage of patients with screw loosening, evaluated from head CT Scan.

    Measured: 3 months

  2. Tissue Reaction (Yes/No)

    Clinical signs of local inflammation process, will be recorded by the end of the 3rd week during patient's visit in outpatient clinic. It will be evaluated by consultants of craniomaxillofacial surgery. The outcome will be presented as the number of patients with signs of local inflammation.

    Measured: 3 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2020
  2. Study start11 Mar 2020
  3. Primary completion31 May 2020
  4. Study completion31 May 2020

Why it stopped: Aerosol risk of COVID-19 spread resulting a slow subject recruitment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04279925
Sponsor's protocol ID
1085/UN2.F1/ETIK/PPM.0002/2019
Status last verified
Apr 2022
First submitted
10 Feb 2020
Last updated
26 Apr 2022
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing ORIF (Open reduction internal fixation): locally-made miniplate and screw and ORIF: Imported miniplate and screw in people with Maxillofacial Injuries and Maxillofacial Prosthesis Implantation, run by Universitas Indonesia at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 26 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 26 Apr 2022). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bone Density (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in